Actemra-Tocilizumab May Not Quell Cytokine Storms

May 23, 2020 · 1m 6s
Actemra-Tocilizumab May Not Quell Cytokine Storms
Description

  Vidcast:  https://youtu.be/7Weu0XfSb3c   The monoclonal antibody tocilizumab that is designed to reduce IL-6 and cytokine storms apparently doesn’t for critically ill CoVid19 patients. This the conclusion of a preliminary case series...

show more
  Vidcast:  https://youtu.be/7Weu0XfSb3c   The monoclonal antibody tocilizumab that is designed to reduce IL-6 and cytokine storms apparently doesn’t for critically ill CoVid19 patients. This the conclusion of a preliminary case series from the University of North Carolina.   Eleven patients with confirmed CoVid19 infections were treated with Actemra.  These patients were either severe or critical and had multiple medical issues including obesity and high blood pressure.     Despite Actemra treatment, all patients experienced significant IL-6 level increases without improvements in their fevers or a reduction in their oxygen requirements.  Two other inflammatory indicators did diminish.   The conclusion: randomized, controlled trials of Actemra must occur before this drug can be widely used.   https://www.medrxiv.org/content/10.1101/2020.05.13.20100404v1.full.pdf   #covid #actemra #tocilizumab #il6 #cytokinestorm  
show less
Information
Author Howard G. Smith MD
Organization Howard G. Smith MD
Website -
Tags

Looks like you don't have any active episode

Browse Spreaker Catalogue to discover great new content

Current

Podcast Cover

Looks like you don't have any episodes in your queue

Browse Spreaker Catalogue to discover great new content

Next Up

Episode Cover Episode Cover

It's so quiet here...

Time to discover new episodes!

Discover
Your Library
Search